Jun 24 |
Eli Lilly seeks to expand Zepbound use to treat sleep apnea
|
Jun 24 |
What Makes Eli Lilly & Company (LLY) a Hot Healthcare Stock Right Now?
|
Jun 24 |
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
|
Jun 24 |
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
|
Jun 24 |
Eli Lilly's Zepbound For Weight Loss Shows Disease Resolution In Obese Sleep Apnea Patients, Lays Further Groundwork For Label Expansion
|
Jun 24 |
Obesity drugs from Altimmune, Hengrui show potential; Lilly details Zepbound sleep apnea data
|
Jun 24 |
How To Invest After A Follow-Through Day
|
Jun 24 |
ResMed Stock Is Sinking. Blame Lilly’s Zepbound Trials for Sleep Apnea.
|
Jun 24 |
These Stocks Are Moving the Most Today: Apple, Meta, Trump Media, RXO, Eli Lilly, ResMed, Under Armour, and More
|
Jun 24 |
Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis)
|